Wenbin Jiang is a corporate insider, tracked as PRESIDENT AND CEO, Director of Cytek Biosciences, Inc. (CTKB). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Wenbin Jiang submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Wenbin Jiang is PRESIDENT AND CEO, Director of Cytek Biosciences, Inc. (CTKB). 7 SEC Form 4 filings on record going back to 2024, most recently on 20 August 2026.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Wenbin Jiang.
InsiderAlpha's records for Wenbin Jiang go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
